Beltrani, V.S., The clinical spectrum of atopic dermatitis (1999) J Allergy Clin Immunol, 104, pp. S87-S98
Thestrup-Pedersen, K., Clinical aspects of atopic dermatitis (2000) Clin Exp Dermatol, 25, pp. 535-543
Griffin, C.E., Deboer, D.J., The ACVD task force on canine atopic dermatitis (XIV): Clinical manifestations of canine atopic dermatitis (2001) Vet Immunol Immunopathol, 81, pp. 255-269
Leung, D.Y.M., Pathogenesis of atopic dermatitis (1999) J Allergy Clin Immunol, 104, pp. S99-S108
Leung, D.Y.M., Atopic dermatitis: New insights and opportunities for therapeutic intervention (2000) J Allergy Clin Immunol, 105, pp. 860-876
Halliwell, R.E.W., Deboer, D.J., The ACVD task force on canine atopic dermatitis (III): The role of antibodies in canine atopic dermatitis (2001) Vet Immunol Immunopathol, 81, pp. 159-168
Hill, P.B., Olivry, T., The ACVD task force on canine atopic dermatitis (V): Biology and role of inflammatory cells in cutaneous allergic reactions (2001) Vet Immunol Immunopathol, 81, pp. 187-198
Leung, D.Y., Hanifin, J.M., Charlesworth, E.N., Disease management of atopic dermatitis: A practice parameter (1997) Ann Allergy Asthma Immunol, 79, pp. 197-211. , Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology Work Group on Atopic Dermatitis
Sidbury, R., Hanifin, J.M., Old, new, and emerging therapy for atopic dermatitis (2000) Dermatol Clin, 18, pp. 1-11
Hoare, C., Li Wan Po, A., Williams, H., Systematic review of treatments for atopic eczema (2000) Health Technol Assess, 4, pp. 1-191
Salek, M.S., Finlay, A.Y., Luscombe, D.K., Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial (1993) Br J Dermatol, 129, pp. 422-430
Van Joost, T., Heule, F., Korstanje, M., Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study (1994) Br J Dermatol, 130, pp. 634-640
Czech, W., Brautigam, M., Weidinger, G., A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life (2000) J Am Acad Dermatol, 42, pp. 653-659
Timonen, P., Friend, D., Abeywickrama, K., Efficacy of low-dose cyclosporin A in psoriasis: Results of dose-finding studies (1990) Br J Dermatol, 122 (SUPPL. 36), pp. 33-39
Olivry, T., Sousa, C.A., The ACVD task force on canine atopic dermatitis (XIX): General principles of therapy (2001) Vet Immunol Immunopathol, 81, pp. 311-316
Naeyaert, J.M., Lachapelle, J.M., Degreef, H., Cyclosporin in atopic dermatitis - Review of the literature and outline of a Belgian consensus (1999) Dermatology, 198, pp. 145-152
Fontaine, J., Olivry, T., Treatment of canine atopic dermatitis with cyclosporine: A pilot clinical study (2001) Vet Rec, 148, pp. 662-663
Olivry, T., Rivierre, C., Jackson, H.A., Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: A blinded randomized prednisolone-controlled trial (2002) Vet Dermatol, 13, pp. 77-87
Sangalli, L., Bortolotti, A., Jiritano, L., Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans (1988) Drug Metab Dispos, 16, pp. 749-753
Ritschel, W.A., Ritschel, G.B., Sabouni, A., Study on the peroral absorption of the endekapeptide cyclosporine A (1989) Methods Find Exp Clin Pharmacol, 11, pp. 281-287
Willemse, T., Atopic skin disease: A review and a reconsideration of diagnostic criteria (1986) J Small Anim Pract, 27, pp. 771-778
Myre, S.A., Schoeder, T.J., Grund, V.R., Critical ketoconazole dosage range for cyclosporin clearance inhibition in the dog (1991) Pharmacology, 43, pp. 233-241
Olivry, T., Guaguère, E., Héripret, D., Treatment of canine atopic dermatitis with the prostaglandin E1 analog misoprostol: An open study (1997) J Dermatol Treatment, 8, pp. 243-247
Deboer, D.J., Moriello, K.A., Pollet, R.A., The efficacy of AHR-13268, an anti-allergenic compound, in the management of pruritus caused by atopic disease in dogs (1992) Am J Vet Res, 53, pp. 532-536
Deboer, D.J., Moriello, K.A., Pollet, R.A., Inability of a short duration treatment with a lipoxygenase inhibitor to reduce clinical signs of canine atopy (1994) Vet Dermatol, 5, pp. 13-16
Fredriksson, T., Pettersson, U., Severe psoriasis-oral therapy with a new retinoid (1978) Dermatologica, 157, pp. 238-244
Severity scoring of atopic dermatitis: The SCORAD index (1993) Dermatology, 186, pp. 23-31
Kunz, B., Oranje, A.P., Labreze, L., Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis (1997) Dermatology, 195, pp. 10-19
Deboer, D.J., Griffin, C.E., The ACVD task force on canine atopic dermatitis (XXI): Antihistamine pharmacotherapy (2001) Vet Immunol Immunopathol, 81, pp. 323-330
Scott, D.W., Miller, W.H., Decker, G.A., Failure of cyproheptadine hydrochloride as an antipruritic agent in allergic dogs: Results of a double-blinded, placebo-controlled study (1992) Cornell Vet, 82, pp. 247-251
Scott, D.W., Miller, W.H., Cayatte, S.M., Failure of terfenadine as an antipruritic agent in atopic dogs - Results of a double-blinded, placebo-controlled study (1994) Can Vet J, 35, pp. 286-288
Olivry, T., Marsella, R., Hillier, A., The ACVD task force on canine atopic dermatitis (XXIII): Are essential fatty acids effective? (2001) Vet Immunol Immunopathol, 81, pp. 347-362
Olivry, T., Sousa, C.A., The ACVD task force on canine atopic dermatitis (XX): Glucocorticoid pharmacotherapy (2001) Vet Immunol Immunopathol, 81, pp. 317-322
Berth-Jones, J., Finlay, A.Y., Zaki, I., Cyclosporine in severe childhood atopic dermatitis: A multicenter study (1996) J Am Acad Dermatol, 34, pp. 1016-1021
Ryffel, B., Donatsch, P., Madörin, M., Toxicological evaluations of cyclosporin A (1983) Arch Toxicol, 53, pp. 107-141
